FxPro review: Medline shares now available for trading
FxPro, a major international broker, has announced the availability of Medline shares for trading, allowing clients to access one of the most closely watched initial public offerings of 2025. Medline (ticker: MDLN.O) made a high-profile debut on Nasdaq, with shares surging about 41% on their first trading day, marking the largest IPO of the year to date and signaling renewed investor appetite for fundamentally strong healthcare companies.
The strong opening performance comes amid broader market uncertainty, underscoring selective demand for established businesses with resilient revenue models and global reach.
Medline’s IPO highlights investor focus on fundamentals
Medline’s listing stands out in an IPO market that has recently been dominated by technology and growth narratives. Founded more than five decades ago, Medline is one of the world’s largest suppliers of medical and surgical products, serving hospitals, clinics and healthcare systems across numerous regions.
The company offers a vast portfolio of hundreds of thousands of products, ranging from everyday medical consumables to advanced healthcare equipment. Its scale, operational stability and exposure to long-term healthcare demand helped attract strong interest from both institutional and retail investors during the offering.
The 41% first-day gain reflects confidence in Medline’s business fundamentals and has positioned the stock as a key name to monitor as the 2025 IPO calendar gathers pace.
Trading Medline shares via FxPro
FxPro clients can now trade Medline shares and take advantage of post-IPO price discovery as the stock establishes itself in public markets. The broker enables trading from as little as 0.01 shares, providing flexible access for traders with different capital levels and strategies.
With FxPro, traders can go long or short on Medline depending on market direction, trade via MetaTrader 5 or the FxPro App, and benefit from fast execution and competitive spreads. The broker also continues to expand access to newly listed stocks, including major IPOs, as they become available.
FxPro offers trading across global equities, indices, forex, commodities and cryptocurrencies, focusing on execution quality and platform choice. As volatility often remains elevated in the weeks following an IPO, Medline’s strong debut could present both opportunities and risks for active market participants.
Read also: FxPro outlines 2026 currency market priorities
Latest FxPro News
-
Afghanistan
-
Albania
-
Algeria
-
Angola
-
Argentina
-
Armenia
-
Australia
-
Austria
-
Azerbaijan
-
Bahamas
-
Bahrain
-
Bangladesh
-
Belarus
-
Belgium
-
Bolivia
-
Botswana
-
Brazil
-
Brunei
-
Bulgaria
-
Cambodia
-
Cameroon
-
Canada
-
Chile
-
China
-
Colombia
-
Congo
-
Costa Rica
-
Cote d'Ivoire
-
Croatia
-
Cuba
-
Cyprus
-
Czechia
-
DR Congo
-
Denmark
-
Dominican Republic
-
Ecuador
-
Egypt
-
El Salvador
-
Estonia
-
Eswatini
-
Ethiopia
-
Finland
-
France
-
Georgia
-
Germany
-
Ghana
-
Greece
-
Haiti
-
Hong Kong
-
Hungary
-
India
-
Indonesia
-
Iran, Islamic republic
-
Iraq
-
Ireland
-
Israel
-
Italy
-
Jamaica
-
Japan
-
Jordan
-
Kazakhstan
-
Kenya
-
Korea
-
Kuwait
-
Kyrgyzstan
-
Laos
-
Latvia
-
Lebanon
-
Lesotho
-
Libya
-
Lithuania
-
Luxembourg
-
Madagascar
-
Malaysia
-
Malta
-
Mauritius
-
Mexico
-
Moldova
-
Mongolia
-
Montenegro
-
Morocco
-
Mozambique
-
Myanmar
-
Namibia
-
Nepal
-
Netherlands
-
New Zealand
-
Nigeria
-
North Macedonia
-
Norway
-
Oman
-
Pakistan
-
Palestine
-
Panama
-
Papua New Guinea
-
Paraguay
-
Peru
-
Philippines
-
Poland
-
Portugal
-
Puerto Rico
-
Qatar
-
Reunion
-
Romania
-
Rwanda
-
Saudi Arabia
-
Serbia
-
Singapore
-
Slovakia
-
Slovenia
-
Somalia
-
South Africa
-
Spain
-
Sri Lanka
-
Sweden
-
Switzerland
-
Syria
-
Taiwan
-
Tajikistan
-
Tanzania
-
Thailand
-
Trinidad and Tobago
-
Tunisia
-
Turkey
-
UAE
-
Uganda
-
Ukraine
-
United Kingdom
-
United States
-
Uruguay
-
Uzbekistan
-
Venezuela
-
Vietnam
-
Yemen
-
Zambia
-
Zimbabwe
- Forex
- Crypto
